Previously treated cases tested for RR-/MDR-TB in Latvia
Latvia: Previously treated cases tested for RR-/MDR-TB was 80.0% in 2022. ▼ Falling
Previously treated cases tested for RR-/MDR-TB in Latvia, 2005–2022
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for previously treated cases tested for rr-/mdr-tb in Latvia is 80.0%, measured in 2022. That is the lowest value across all 15 years on record.
The figure is down 13.0% on the previous year and down 9.1% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Latvia peaked at 95.0% in 2008 and was at its lowest, 80.0%, in 2022.
Latvia ranks 114th of 180 countries on this measure, in the middle of the range.
The long-run direction has been consistently falling across the 15 years of available data.
Previously treated cases tested for RR-/MDR-TB in Latvia, year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 89.0% | — |
| 2006 | 93.0% | +4.5% |
| 2007 | 94.0% | +1.1% |
| 2008 | 95.0% | +1.1% |
| 2009 | 91.0% | -4.2% |
| 2010 | 94.0% | +3.3% |
| 2011 | 85.0% | -9.6% |
| 2012 | 88.0% | +3.5% |
| 2013 | 85.0% | -3.4% |
| 2014 | 86.0% | +1.2% |
| 2015 | 89.0% | +3.5% |
| 2016 | 90.0% | +1.1% |
| 2017 | 88.0% | -2.2% |
| 2021 | 92.0% | +4.5% |
| 2022 | 80.0% | -13.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 92.4% | 89.0% | 95.0% | 5 |
| 2010s | 88.1% | 85.0% | 94.0% | 8 |
| 2020s | 86.0% | 80.0% | 92.0% | 2 |
Countries ranked near Latvia
More health data for Latvia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3876 % change on previous year (2090)
- Heat deaths vs projected death rates 1,593 (2090)
- Un projection of annual infant deaths 4 (2100)
- Population ages 65 and above, female, annual growth rate 0.7132 % change on previous year (2025)
- Population ages 65 and above, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, female, per capita 0.1458 units per person (2025)
- Population ages 65 and above, male, annual growth rate 1.88 % change on previous year (2025)
- Population ages 65 and above, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, male, per capita 0.0761 units per person (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Latvia?
- Previously treated cases tested for rr-/mdr-tb in Latvia was 80.0% in 2022, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Latvia?
- The highest recorded value was 95.0% in 2008.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Latvia?
- The lowest recorded value was 80.0% in 2022.
- How does Latvia rank for previously treated cases tested for rr-/mdr-tb?
- Latvia ranks 114th out of 180 countries with data for 2022.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Latvia?
- Over the last ten years it is down 9.1%. The long-run trend across the full record is falling.
- Where does this Latvia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 15 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).